OEP PHARMA

Welcome to the Brand page for “OEP PHARMA”, which is offered here for The mark consists of the stylized words oep pharma to the right of a miscellaneous design having an overall diamond shape.;drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; pharmaceutical products for the prevention and treatment of cancer; therapeutic pharmaceuticals for the treatment of cancer, cardiovascular diseases, metabolic diseases, musculoskeletal diseases, infectious diseases, and neurodegenerative diseases; pharmaceutical preparations for the treatment of hyperlipidemia; local anesthetics; drug delivery agents in the form of a coating for tablets and capsules that facilitate the delivery of a wide range of pharmaceuticals; medicinal preparations of the treatment of infectious diseases and for use in oncology; anesthetics; anesthetics for surgical purposes; pharmaceutical preparations for treating diabetes; anti-diabetic pharmaceuticals; cardiovascular agents for medical purposes; drug delivery agents in the form of transdermal patches, coatings for tablets, and synthetic materials that facilitate the delivery of pharmaceutical preparations; skeletal muscle relaxants; pharmaceutical preparations for treating hypertension; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations for the treatment of cancer, cardiovascular diseases, metabolic diseases, musculoskeletal diseases, infectious diseases, and neurodegenerative diseases; anesthetics for surgical and non-surgical use; pharmaceuticals, lipid lowering agents; pharmaceutical preparations for use in chemotherapy; prescription and non-prescription medicines, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; transdermal patches for use in the treatment of neurodegenerative disease; cardiovascular pharmaceuticals; hypolipidemic agents; anesthetics for surgical use; pain relief medication; pharmaceutical products for the treatment of cancer; hypolipidemic agents;pharma;.

Its status is currently believed to be active. Its class is unavailable. “OEP PHARMA” is believed to be currently owned by “ORIENT EUROPHARMA CO., LTD.”

Owner:
ORIENT EUROPHARMA CO., LTD.
Owner Details
Description:
The mark consists of the stylized words OEP Pharma to the right of a miscellaneous design having an overall diamond shape.;Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceuticals for the treatment of cancer, cardiovascular diseases, metabolic diseases, musculoskeletal diseases, infectious diseases, and neurodegenerative diseases; Pharmaceutical preparations for the treatment of hyperlipidemia; Local anesthetics; Drug delivery agents in the form of a coating for tablets and capsules that facilitate the delivery of a wide range of pharmaceuticals; Medicinal preparations of the treatment of infectious diseases and for use in oncology; Anesthetics; Anesthetics for surgical purposes; Pharmaceutical preparations for treating diabetes; Anti-diabetic pharmaceuticals; Cardiovascular agents for medical purposes; Drug delivery agents in the form of transdermal patches, coatings for tablets, and synthetic materials that facilitate the delivery of pharmaceutical preparations; Skeletal muscle relaxants; Pharmaceutical preparations for treating hypertension; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases, metabolic diseases, musculoskeletal diseases, infectious diseases, and neurodegenerative diseases; Anesthetics for surgical and non-surgical use; Pharmaceuticals, lipid lowering agents; Pharmaceutical preparations for use in chemotherapy; Prescription and non-prescription medicines, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Transdermal patches for use in the treatment of neurodegenerative disease; Cardiovascular pharmaceuticals; Hypolipidemic agents; Anesthetics for surgical use; Pain relief medication; Pharmaceutical products for the treatment of cancer; Hypolipidemic agents;PHARMA;
Categories: